RECODE · 연구동향생성일 2026-10-31

연구동향

기준 논문: Frontal dysfunction underlies depressive syndrome in Alzheimer disease: a FDG-PET study

Am J Geriatr Psychiatry 14(7):625-628 · 2006 · PMID 16816017

검색 방법

이 논문의 제목과 주제어를 바탕으로 이 논문이 속한 연구 분야를 묻는 질문을 만들어 ReviewFast에 넣어 2026-10-31에 검색했습니다. ReviewFast가 PubMed를 검색하고, AI 모델(Jev)이 제목과 초록을 읽어 질문과의 관련도를 매긴 뒤 주제별로 묶었습니다.

452편 검색→433편 판독→56편 선별 (관련도 0.5 이상)

질문과 PubMed 검색식 보기질문: Depression in Alzheimer disease and FDG-PET (Depression[tiab] OR depressive[tiab] OR "depressive symptoms"[tiab]) AND (("Alzheimer disease"[tiab] OR Alzheimer*[tiab] OR "Alzheimer's disease"[tiab] OR "Alzheimer Disease"[MeSH Terms]) AND ("fluorodeoxyglucose F18"[tiab] OR FDG[tiab] OR "positron emission tomography"[tiab] OR PET[tiab] OR "Positron-Emission Tomography"[MeSH Terms] OR "Fluorodeoxyglucose F18"[MeSH Terms]))

출판 연도

1985: 1편1198519901991: 1편11993: 2편21994: 1편11995: 1편119951998: 1편11999: 1편120002001: 1편12005: 2편220052006: 1편12008: 1편12009: 1편12010: 2편220102012: 1편12014: 1편12015: 4편420152016: 3편32018: 3편32019: 1편12020: 2편220202021: 6편62022: 7편72023: 3편32024: 4편42025: 3편32026: 2편22026

선별된 56편의 출판 연도. 검색일(2026-10-31) 기준이며, 그 이후 논문은 들어 있지 않습니다.

주제별 논문

주제 이름은 ReviewFast가 초록의 단어로 자동으로 붙인 것입니다. 왼쪽 숫자는 관련도(0–1)입니다. RECODE 는 우리 연구팀 논문입니다.

01metabolism · glucose23편

  1. 0.96

    Frontal dysfunction underlies depressive syndrome in Alzheimer disease: a FDG-PET study 이 논문

    Lee DY, Choo IH, Jhoo JH et al. · The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2006

  2. 0.96

    Frontal lobe hypometabolism and depression in Alzheimer's disease

    Hirono N, Mori E, Ishii K et al. · Neurology · 1998

  3. 0.96

    The mediating effect of (18)F-FDG metabolism in right caudate between depressive symptoms and cognitive function in Alzheimer's disease

    Wang B, Cui C, Chen Y et al. · Frontiers in aging neuroscience · 2024

  4. 0.95

    Regional cerebral metabolism in early Alzheimer's disease with clinically significant apathy or depression

    Holthoff VA, Beuthien-Baumann B, Kalbe E et al. · Biological psychiatry · 2005

  5. 0.94

    Altered brain serotonin transporter and associated glucose metabolism in Alzheimer disease

    Ouchi Y, Yoshikawa E, Futatsubashi M et al. · Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2009

  6. 0.92

    The relationship between psychiatric symptoms and regional cortical metabolism in Alzheimer's disease

    Sultzer DL, Mahler ME, Mandelkern MA et al. · The Journal of neuropsychiatry and clinical neurosciences · 1995

  7. 0.92

    Frontal Dysfunction Underlies Depression in Mild Cognitive Impairment: A FDG-PET Study RECODE

    Lee HS, Choo IH, Lee DY et al. · Psychiatry investigation · 2010

  8. 0.92

    Regional cerebral glucose metabolism in late-life depression and Alzheimer disease: a preliminary positron emission tomography study

    Kumar A, Newberg A, Alavi A et al. · Proceedings of the National Academy of Sciences of the United States of America · 1993

  9. 0.89

    CSF Amyloid-beta42 associates with neuropsychiatric and cognitive outcomes via cerebral glucose metabolism

    Azargoonjahromi A, Nasiri H · Molecular brain · 2025

  10. 0.89

    The effects of cerebral amyloidopathy on regional glucose metabolism in older adults with depression and mild cognitive impairment while performing memory tasks

    Lee ES, Youn H, Hyung WSW et al. · The European journal of neuroscience · 2021

  11. 0.89

    Changes in glucose metabolism in dementia of the Alzheimer type compared with depression: a preliminary report

    Guze BH, Baxter LRJ, Schwartz JM et al. · Psychiatry research · 1991

  12. 0.87

    Patterns of cerebral glucose utilization in depression, multiple infarct dementia, and Alzheimer's disease

    Kuhl DE, Metter EJ, Riege WH · Research publications - Association for Research in Nervous and Mental Disease · 1985

  13. 0.86

    Metabolic compensation and depression in Alzheimer's disease

    Caroli A, Lorenzi M, Geroldi C et al. · Dementia and geriatric cognitive disorders · 2010

  14. 0.86

    Regional glucose metabolism due to the presence of cerebral amyloidopathy in older adults with depression and mild cognitive impairment

    Youn H, Lee ES, Lee S et al. · Journal of affective disorders · 2018

  15. 0.81

    In vivo MRI Structural and PET Metabolic Connectivity Study of Dopamine Pathways in Alzheimer's Disease

    Iaccarino L, Sala A, Caminiti SP et al. · Journal of Alzheimer's disease : JAD · 2020

  16. 0.80

    Metabolic patterns associated with the clinical response to galantamine therapy: a fludeoxyglucose f 18 positron emission tomographic study

    Mega MS, Dinov ID, Porter V et al. · Archives of neurology · 2005

  17. 0.79

    Psychiatric symptoms associated with cortical-subcortical dysfunction in Alzheimer's disease

    Lopez OL, Zivkovic S, Smith G et al. · The Journal of neuropsychiatry and clinical neurosciences · 2001

  18. 0.78

    Depressive Pseudodementia with Reversible AD-like Brain Hypometabolism: A Case Report and a Review of the Literature

    Pozzi FE, Licciardo D, Musarra M et al. · Journal of personalized medicine · 2022

  19. 0.76

    The relationship between fasting serum glucose and cerebral glucose metabolism in late-life depression and normal aging

    Marano CM, Workman CI, Lyman CH et al. · Psychiatry research · 2014

  20. 0.74

    Drug-induced cerebral glucose metabolism resembling Alzheimer's Disease: a case study

    Riepe MW, Walther B, Vonend C et al. · BMC psychiatry · 2015

  21. 0.73

    Hypometabolism in Brain of Cognitively Normal Patients with Depressive Symptoms is Accompanied by Atrophy-Related Partial Volume Effects

    Brendel M, Reinisch V, Kalinowski E et al. · Current Alzheimer research · 2016

  22. 0.73

    Neuropsychological Performance Is Correlated With Tau Protein Deposition and Glucose Metabolism in Patients With Alzheimer's Disease

    Qiao Z, Wang G, Zhao X et al. · Frontiers in aging neuroscience · 2022

  23. 0.55

    Glucose metabolism in the right middle temporal gyrus could be a potential biomarker for subjective cognitive decline: a study of a Han population

    Dong QY, Li TR, Jiang XY et al. · Alzheimer's research & therapy · 2021

02cognitive impairment · deposition9편

  1. 0.92

    Neurobiological correlates of depressive symptoms in people with subjective and mild cognitive impairment

    Auning E, Selnes P, Grambaite R et al. · Acta psychiatrica Scandinavica · 2015

  2. 0.92

    When Cognitive Decline and Depression Coexist in the Elderly: CSF Biomarkers Analysis Can Differentiate Alzheimer's Disease from Late-Life Depression

    Liguori C, Pierantozzi M, Chiaravalloti A et al. · Frontiers in aging neuroscience · 2018

  3. 0.83

    Depressive symptoms accelerate cognitive decline in amyloid-positive MCI patients

    Brendel M, Pogarell O, Xiong G et al. · European journal of nuclear medicine and molecular imaging · 2015

  4. 0.83

    Depressive symptoms in cognitively unimpaired older adults are associated with lower structural and functional integrity in a frontolimbic network

    Touron E, Moulinet I, Kuhn E et al. · Molecular psychiatry · 2022

  5. 0.66

    Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two-Year Follow-Up in Mild Cognitive Impairment and Alzheimer's Disease Patients with Depressive Symptoms

    Brendel M, Sauerbeck J, Greven S et al. · Journal of Alzheimer's disease : JAD · 2018

  6. 0.65

    Decreased Cerebral Amyloid-beta Depositions in Patients With a Lifetime History of Major Depression With Suspected Non-Alzheimer Pathophysiology

    Wu KY, Lin KJ, Chen CH et al. · Frontiers in aging neuroscience · 2022

  7. 0.55

    An optimized MRI and PET based clinical protocol for improving the differential diagnosis of geriatric depression and Alzheimer's disease

    Emsell L, Vanhaute H, Vansteelandt K et al. · Psychiatry research. Neuroimaging · 2022

  8. 0.54

    Inclusion criteria provide heterogeneity in baseline profiles of patients with mild cognitive impairment: comparison of two prospective cohort studies

    Kawashima S, Ito K, Kato T · BMJ open · 2012

  9. 0.52

    Atrophy, hypometabolism and implication regarding pathology in late-life major depression with suspected non-alzheimer pathophysiology (SNAP)

    Wu KY, Lin KJ, Chen CH et al. · Biomedical journal · 2023

03cognitive decline · biomarkers9편

  1. 0.90

    Longitudinal association of depressive symptoms with cognition and neuroimaging biomarkers in cognitively unimpaired older adults, mild cognitive impairment, and Alzheimer's disease

    Hu Y, Zhu T, Yuan M et al. · Cerebral cortex (New York, N.Y. : 1991) · 2024

  2. 0.84

    Associations of the Rate of Change in Geriatric Depression Scale with Amyloid and Cerebral Glucose Metabolism in Cognitively Normal Older Adults: A Longitudinal Study

    Wang ZT, Shen XN, Ma YH et al. · Journal of affective disorders · 2021

  3. 0.70

    Sex-specificities in anxiety and depressive symptoms across the lifespan and their links with multimodal neuroimaging

    Moulinet I, Landeau B, Touron E et al. · Journal of affective disorders · 2022

  4. 0.69

    Tau PET positivity predicts clinically relevant cognitive decline driven by Alzheimer's disease compared to comorbid cases; proof of concept in the ADNI study

    Ioannou K, Bucci M, Tzortzakakis A et al. · Molecular psychiatry · 2025

  5. 0.68

    Cross-sectional and longitudinal characterization of SCD patients recruited from the community versus from a memory clinic: subjective cognitive decline, psychoaffective factors, cognitive performances, and atrophy progression over time

    Kuhn E, Moulinet I, Perrotin A et al. · Alzheimer's research & therapy · 2019

  6. 0.67

    Neuropsychiatric Symptoms and Alzheimer Disease Biomarkers Independently Predict Progression to Incident Cognitive Impairment

    Babulal GM, Chen L, Murphy SA et al. · The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2023

  7. 0.64

    The clinical and neuropsychological profiles of Alzheimer's disease with white matter hyperintensity in North China

    Chen Y, Wang Y, Zhang M et al. · Frontiers in neurology · 2024

  8. 0.57

    Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI

    Landau SM, Horng A, Fero A et al. · Neurology · 2016

  9. 0.55

    Prediction of cognitive decline in healthy aging based on neuropsychiatric symptoms and PET-biomarkers of Alzheimer's disease

    Ronat L, Hanganu A, Chylinski D et al. · Journal of neurology · 2024

04diagnosis · review8편

  1. 0.77

    Deep Learning With 18F-Fluorodeoxyglucose-PET Gives Valid Diagnoses for the Uncertain Cases in Memory Impairment of Alzheimer's Disease

    Zhang W, Zhang T, Pan T et al. · Frontiers in aging neuroscience · 2021

  2. 0.77

    [(18)F]Fluorodeoxyglucose position emission tomography for differential diagnosis of depressive cognitive impairment: incremental value compared with clinical diagnosis

    Hellwig S, Frings L, Heibel M et al. · The British journal of psychiatry : the journal of mental science · 2026

  3. 0.76

    Early-onset Alzheimer's disease with depression as the first symptom: a case report with literature review

    Liu M, Xie X, Xie J et al. · Frontiers in psychiatry · 2023

  4. 0.68

    Differential Diagnosis Between Alzheimer's Disease-Related Depression and Pseudo-Dementia in Depression: A New Indication for Amyloid-beta Imaging?

    Leonhardi J, Barthel H, Speerforck S et al. · Journal of Alzheimer's disease : JAD · 2022

  5. 0.61

    On the conundrum of cognitive impairment due to depressive disorder in older patients

    Lanza CE, Sejunaite K, Steindel C et al. · PloS one · 2020

  6. 0.58

    Familial Alzheimer's disease. A pedigree with a mis-sense mutation in the amyloid precursor protein gene (amyloid precursor protein 717 valine-->glycine)

    Kennedy AM, Newman S, McCaddon A et al. · Brain : a journal of neurology · 1993

  7. 0.52

    Multiscale networks in Alzheimer's disease identify brain hypometabolism as central across biological scales

    Lara-Simon E, Gispert JD, Garcia-Ojalvo J et al. · PLoS computational biology · 2025

  8. 0.51

    Clinical correlates of PET- and SPECT-identified defects in dementia

    Mayberg HS · The Journal of clinical psychiatry · 1994

05neuropsychiatric symptoms · inventory3편

  1. 0.88

    Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer's disease

    Ng KP, Pascoal TA, Mathotaarachchi S et al. · Translational neurodegeneration · 2021

  2. 0.86

    FDG-PET and Neuropsychiatric Symptoms among Cognitively Normal Elderly Persons: The Mayo Clinic Study of Aging

    Krell-Roesch J, Ruider H, Lowe VJ et al. · Journal of Alzheimer's disease : JAD · 2016

  3. 0.85

    Brain Regional Glucose Metabolism, Neuropsychiatric Symptoms, and the Risk of Incident Mild Cognitive Impairment: The Mayo Clinic Study of Aging

    Krell-Roesch J, Syrjanen JA, Vassilaki M et al. · The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2021

06tau · older2편

  1. 0.79

    Depressive Symptoms and Biomarkers of Alzheimer's Disease in Cognitively Normal Older Adults

    Donovan NJ, Hsu DC, Dagley AS et al. · Journal of Alzheimer's disease : JAD · 2015

  2. 0.54

    PET-measured tau deposition in emotion-related brain regions is differentially associated with depressive symptoms in individuals with versus without Alzheimer's disease pathology

    Glaubitz E, Wang XH, Xi K et al. · Behavioural brain research · 2026

07binding · brain2편

  1. 0.57

    Reduced 5-HT2A receptor binding in patients with mild cognitive impairment

    Hasselbalch SG, Madsen K, Svarer C et al. · Neurobiology of aging · 2008

  2. 0.52

    PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders

    Meltzer CC, Price JC, Mathis CA et al. · The American journal of psychiatry · 1999